Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2026-01-01 @ 2:57 PM
Study NCT ID:
NCT00045669
Status:
COMPLETED
Last Update Posted:
2019-02-15
First Post:
2002-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
Sponsor:
University Health Network, Toronto
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-07
Start Date Type:
None
Primary Completion Date:
2004-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-01
Completion Date Type:
ACTUAL
First Submit Date:
2002-09-06
First Submit QC Date:
None
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-13
Last Update Post Date:
2019-02-15
Last Update Post Date Type:
ACTUAL